Personalized Cancer Treatment: Harnessing the Power of Molecular Research
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 218
Special Issue Editors
Interests: prostate cancer; colorectal cancer; genitourinary cancers
Interests: prostate cancer; radiation oncology; radiation therapy; radiation biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are living in an era of unprecedented development in cancer, both in the diagnosis of the disease with the introduction of advance imaging as well as with the implementation of molecular biomarkers which have diagnostic and prognostic implications that can allow us to personalize the treatment for our patients.
Molecular research is at the forefront of efforts to personalize cancer treatment. By comprehensively studying the molecular characteristics of tumors, identifying biomarkers, and designing targeted therapies, researchers are paving the way for more effective and precise cancer treatments. As molecular research continues to advance, personalized cancer treatment holds tremendous potential to improve patient outcomes and ultimately transform the landscape of cancer care.
This Special Issue aims to explore the molecular and/or therapeutic advances that already have a clinical use or that can transform the diagnostic and treatment paths of different tumors in the coming years. Please kindly note data on molecular mechanisms or pathophysiology are essential, and papers that only contain clinical trials/data are not acceptable.
Dr. Fernando López-Campos
Dr. Felipe Couñago
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- survival outcomes in oncologic setting
- molecular biomarkers
- advanced imaging
- adaptive cancer treatment
- precision cancer treatment
- targeted therapies and Immunotherapy
- personalized radiotherapy
